Impact of rare and common genetic variation in the interleukin-1 pathway on human cytokine responses
0301 basic medicine
BLOCKADE
Interleukin-1beta
SUSCEPTIBILITY
QH426-470
DISEASE
common variants
Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences
0303 health sciences
IMMUNE-RESPONSES
Systems Biology
R
High-Throughput Nucleotide Sequencing
Healthy Volunteers
FAMILY
3. Good health
MOLECULAR INVERSION PROBES
Interleukin-1 pathway
Medicine
Cytokines
AUTOPHAGY
Disease Susceptibility
Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences
Systems biology
Signal Transduction
immunological mechanisms
Radboud University Medical Center
Immunophenotyping
region-based analysis
03 medical and health sciences
INFLAMMATION
Region-based analysis
Genetics
Humans
Inflammation
RECEPTOR
Common variants
Research
Gene Expression Profiling
rare variants
Genetic Variation
Rare variants
Cell Biology
SKAT
Immunity, Innate
Gene Expression Regulation
Immunological mechanisms
Human Genetics - Radboud University Medical Center
interleukin-1 pathway
VARIANT ASSOCIATION
Biomarkers
Interleukin-1
DOI:
10.1186/s13073-021-00907-w
Publication Date:
2021-05-25T07:02:27Z
AUTHORS (14)
ABSTRACT
AbstractBackgroundThe interleukin (IL)-1 pathway is primarily associated with innate immunological defense and plays a major role in the induction and regulation of inflammation. Both common and rare genetic variation in this pathway underlies various inflammation-mediated diseases, but the role of rare variants relative to common variants in immune response variability in healthy individuals remains unclear.MethodsWe performed molecular inversion probe sequencing on 48 IL-1 pathway-related genes in 463 healthy individuals from the Human Functional Genomics Project. We functionally grouped common and rare variants, over gene, subpathway, and inflammatory levels and performed the Sequence Kernel Association Test to test for association with in vitro stimulation-induced cytokine responses; specifically, IL-1β and IL-6 cytokine measurements upon stimulations that represent an array of microbial infections: lipopolysaccharide (LPS), phytohaemagglutinin (PHA),Candida albicans(C. albicans), andStaphylococcus aureus(S. aureus).ResultsWe identified a burden ofNCF4rare variants with PHA-induced IL-6 cytokine and showed that the respective carriers are in the 1% lowest IL-6 producers. Collapsing rare variants in IL-1 subpathway genes produces a bidirectional association with LPS-induced IL-1β cytokine levels, which is reflected by a significant Spearman correlation. On the inflammatory level, we identified a burden of rare variants in genes encoding for proteins with an anti-inflammatory function withS. aureus-induced IL-6 cytokine. In contrast to these rare variant findings which were based on different types of stimuli, common variant associations were exclusively identified withC. albicans-induced cytokine over various levels of grouping, from the gene, to subpathway, to inflammatory level.ConclusionsIn conclusion, this study shows that functionally grouping common and rare genetic variants enables the elucidation IL-1-mediated biological mechanisms, specifically, for IL-1β and IL-6 cytokine responses induced by various stimuli. The framework used in this study may allow for the analysis of rare and common genetic variants in a wider variety of (non-immune) complex phenotypes and therefore has the potential to contribute to better understanding of unresolved, complex traits and diseases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....